Cyclosporine A Reduction and Withdrawal in Liver Transplantation: A Risk-Benefit Analysis

Author： Golling M. Frankenberg M.V. Hofmann W.J. Lohse A. Herfarth C. Otto G.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.29, Iss.7, 1997-11, pp. : 2819-2821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orthotopic liver transplantation with poor neurologic outcome in valproate-associated liver failure: a need for critical risk-benefit appraisal in the use of valproate

By Thomson M.A. Lynch S. Strong R. Shepherd R.W. Marsh W.

Transplantation Proceedings, Vol. 32, Iss. 1, 2000-02 ,pp. : 200-203

Elsevier

Access to resources Recommend Favorite

Optimization of cyclosporine therapy in liver transplantation

By Pollard S.G. Lodge J.P.A.

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1816-1818

Elsevier

Access to resources Recommend Favorite

Tacrolimus is superior to cyclosporine in liver transplantation

By Busuttil R.W. Holt C.D.

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2174-2178

Elsevier

Access to resources Recommend Favorite

Tacrolimus (FK506) Is Superior to Cyclosporine in Liver Transplantation

By Busuttil R.W. Holt C.D.

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 534-538

Elsevier

Access to resources Recommend Favorite

Neoral Without Intravenous Cyclosporine in Liver Transplantation

By Hemming A.W. Greig P.D. Cattral M.S. Chung S.W. Lilly L.B. Aljumah A.A. Levy G.A.

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 543-543

Elsevier

Access to resources Recommend Favorite